Argenx Se earnings were $1.9B for the trailing 12 months ending Jun 30, 2026, with 26% growth year over year. The latest ARGX earnings report on Jun 30, 2026 announced Q2 2026 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ARGX reported annual earnings of $1.5B, with 75.2% growth. The next ARGX earnings date is Oct 29, 2026.
ARGX past earnings growth
How has ARGX's earnings growth performed historically?
On ARGX's earnings call on Jul 23, 2026, Argenx Se (NASDAQ: ARGX) reported Q2 2026 earnings per share (EPS) of N/A, up N/A year over year. Total ARGX earnings for the quarter were N/A. In the same quarter last year, Argenx Se's earnings per share (EPS) was N/A.
The next ARGX earnings date is Oct 29, 2026. Add ARGX to your watchlist to be reminded of Argenx Se's next earnings date.
Is Argenx Se profitable or losing money?
As of the last Argenx Se earnings report, Argenx Se is currently profitable. Argenx Se's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $1.95 billion, a 29.37% increase year over year.
What was ARGX's earnings growth in the past year?
As of Argenx Se's earnings date in Jul 23, 2026, Argenx Se's earnings has grown 26.02% year over year. This is 7.98 percentage points higher than the US Biotechnology industry earnings growth rate of 18.03%. ARGX earnings in the past year totalled $1.95 billion.
What are Argenx Se's earnings expectations?
The current EPS estimate for Argenx Se's earnings report in Oct 29, 2026 is $7.62.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.